Basic Information
| LncRNA/CircRNA Name | circFNTA |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR |
| Sample | bladder cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | circFNTA expression is elevated in BCa tissues, and results from a BCa mouse model indicate that depletion of circFNTA leads to the suppression of BCa metastases and increased cisplatin chemo-sensitivity. |
| Pubmed ID | 32052578 |
| Year | 2020 |
| Title | Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion |
External Links
| Links for circFNTA | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |